Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mental health outcomes in older breast cancer survivors: Five-year follow-up from the CLIMB study.
Lemij AA, de Glas NA, Derks MGM, Linthorst-Niers EMH, Guicherit OR, van der Pol CC, Lans TE, van Dalen T, Vulink AJE, Merkus JWS, van Gerven L, van den Bos F, Rius Ottenheim N, Liefers GJ, Portielje JEA. Lemij AA, et al. Among authors: van den bos f, van der pol cc, van dalen t, van gerven l. Eur J Cancer. 2023 Jul;187:87-95. doi: 10.1016/j.ejca.2023.04.001. Epub 2023 Apr 5. Eur J Cancer. 2023. PMID: 37130464 Free article.
Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands - A comparison of two national prospective longitudinal multi-centre cohort studies.
van der Plas-Krijgsman WG, Morgan JL, de Glas NA, de Boer AZ, Martin CL, Holmes GR, Ward SE, Chater T, Reed MW, Merkus JWS, van Dalen T, Vulink AJE, van Gerven L, Guicherit OR, Linthorst-Niers E, Lans TE, Bastiaannet E, Portielje JEA, Liefers GJ, Wyld L. van der Plas-Krijgsman WG, et al. Among authors: van dalen t, van gerven l. Eur J Cancer. 2022 Mar;163:189-199. doi: 10.1016/j.ejca.2021.12.018. Epub 2022 Jan 23. Eur J Cancer. 2022. PMID: 35081505 Free PMC article.
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer.
Lemij AA, de Glas NA, Derks MGM, Bastiaannet E, Merkus JWS, Lans TE, van der Pol CC, van Dalen T, Vulink AJE, van Gerven L, Guicherit OR, Linthorst-Niers EMH, van den Bos F, Kroep JR, Liefers GJ, Portielje JEA. Lemij AA, et al. Among authors: van den bos f, van der pol cc, van dalen t, van gerven l. Breast Cancer Res Treat. 2022 Jun;193(3):567-577. doi: 10.1007/s10549-022-06583-7. Epub 2022 Apr 19. Breast Cancer Res Treat. 2022. PMID: 35441273 Free PMC article.
Predicting postoperative complications and their impact on quality of life and functional status in older patients with breast cancer.
Lemij AA, van der Plas-Krijgsman WG, Bastiaannet E, Merkus JWS, van Dalen T, Vulink AJE, van Gerven L, Guicherit OR, Linthorst-Niers EMH, Lans TE, van der Pol CC, Wyld L, Morgan JL, Portielje JEA, de Glas NA, Liefers GJ. Lemij AA, et al. Among authors: van der plas krijgsman wg, van der pol cc, van dalen t, van gerven l. Br J Surg. 2022 Jun 14;109(7):595-602. doi: 10.1093/bjs/znac014. Br J Surg. 2022. PMID: 35470383
Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
Baltussen JC, Derks MGM, Lemij AA, de Glas NA, Fiocco M, Linthorst-Niers EMH, Vulink AJE, van Gerven L, Guicherit OR, van Dalen T, Merkus JWS, Lans TE, van der Pol CC, Mooijaart SP, Portielje JEA, Liefers GJ. Baltussen JC, et al. Among authors: van der pol cc, van dalen t, van gerven l. Eur J Cancer. 2023 May;185:1-10. doi: 10.1016/j.ejca.2023.02.008. Epub 2023 Feb 17. Eur J Cancer. 2023. PMID: 36933518 Free article.
Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study.
Lemij AA, Liefers GJ, Derks MGM, Bastiaannet E, Fiocco M, Lans TE, van der Pol CC, Vulink AJE, van Gerven L, Guicherit OR, Linthorst-Niers EMH, Merkus JWS, van Dalen T, Portielje JEA, de Glas NA. Lemij AA, et al. Among authors: van der pol cc, van dalen t, van gerven l. Oncologist. 2023 Jun 2;28(6):e317-e323. doi: 10.1093/oncolo/oyad027. Oncologist. 2023. PMID: 36943287 Free PMC article.
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial.
Opdam M, van Rossum AGJ, Hoogstraat M, Bounova G, Horlings HM, van Werkhoven E, Mandjes IAM, van Leeuwen-Stok AE, Canisius S, van Tinteren H, Imholz ALT, Portielje JEA, Bos MEMM, Bakker S, Wesseling J, Kester L, van Rheenen J, Rutgers EJ, de Menezes RX, Wessels LFA, Kok M, Oosterkamp HM, Linn SC; MATADOR trialists’ group for the Dutch Breast Cancer Research Group (BOOG). Opdam M, et al. iScience. 2024 Jun 29;27(8):110425. doi: 10.1016/j.isci.2024.110425. eCollection 2024 Aug 16. iScience. 2024. PMID: 39206149 Free PMC article.
Colon carcinoma presenting as ovarian metastasis.
Kemps PG, Bol M, Steller EJA, de Pont LMH, Holterhues C, van Gerven L, Kolkman W. Kemps PG, et al. Among authors: van gerven l. Radiol Case Rep. 2021 Jul 23;16(9):2799-2803. doi: 10.1016/j.radcr.2021.06.072. eCollection 2021 Sep. Radiol Case Rep. 2021. PMID: 34367398 Free PMC article.
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR).
Seys SF, Schneider S, de Kinderen J, Reitsma S, Cavaliere C, Tomazic PV, Morgenstern C, Mortuaire G, Wagenmann M, Bettio G, Ciofalo A, Diamant Z, Eckl-Dorna J, Fokkens WJ, Holzmeister C, Mariën G, Masieri S, Otten J, Scheckenbach K, Tu A, Bachert C; CHRINOSOR consortium. Seys SF, et al. J Allergy Clin Immunol. 2024 Oct 30:S0091-6749(24)01160-6. doi: 10.1016/j.jaci.2024.10.016. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39486595
97 results